A Multicenter, Multinational, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra; When Used In Routine Medical Practice (LIBERATE)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms LIBERATE
- Sponsors Biogen
- 27 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Apr 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2020 as reported by ClinicalTrials.gov record.
- 10 May 2012 Additional trial location (Norway) added as reported by ClinicalTrials.gov.